NFKB1 and gastric cancer: The silencing of RELM-α expression by Ad5/F35-siRNA treatment significantly inhibited NF-κB activation and attenuated VEGF and MMP-9 expression as well as cell migratory and invasive ability in SGC7901 and MKN45 gastric cancer cells [111].